Monthly Archives: July 2011

Generics Win in an Express Scripts/Medco deal

By Ben Comer | Published: July 27, 2011
As a preferred generics supplier to Medco’s mail-order business, Novartis’ Sandoz division, for one, should be waiting with bated breath – and champagne at the ready – for an FTC approval of Express Scripts’ proposed $29.1 billion acquisition of Medco, which would combine two of the three largest pharmacy benefits managers (PBM), according to industry [...]
Posted in Deals, Strategy, pricing | Tagged , , , , , , | 4 Comments

FDA Finding Fuels Indian Crackdown on Sub-standard Drugs

By Guest Blogger | Published: July 27, 2011
By Mangesh Sai, Asia Correspondent. A routine monthly inspection carried out by the Food and Drugs Administration (FDA) authorities in the state of Maharashtra, India, last month noted an increase in the number of sub-standard drug samples raising apprehensions about the availability of safe and genuine drugs in the state. Officials pointed out that 26 drug samples [...]
Posted in Anti-counterfeiting, Global, Guest Blog, IP, Safety | Tagged , , , , | Leave a comment

Europe: Into the HTA Fray

By Guest Blogger | Published: July 27, 2011
Reflector finds some surprising common ground in what should be two very different HTA reports. Just like with buses, you wait for ages for an international review of health technology assessment to come along, then two turn up at once.
Posted in Europe, Global, Guest Blog, Regulatory, healthcare, pricing | Tagged , , , , , | Leave a comment

Does Pharma Have a Debt Crisis Strategy?

By William Looney and Ben Comer | Published: July 20, 2011
The Obama Administration’s proposed fiscal budget for 2012 suggested that all bets are off for biopharmaceutical revenue safeguards, but it never had a chance with Congress, as evidenced by a unanimous no-thank-you from the Senate in late May. But that was before debt ceiling talks and the alleged possibility of a default emerged as the [...]
Posted in Corporate Responsibility, Europe, Global, Strategy, healthcare, leadership, pricing | Tagged , , , , , | 1 Comment

Doing More With Less: A Leadership Perspective

By Jennifer Ringler | Published: July 19, 2011
Steven Blum, Director of Health Economics at Forest Laboratories and one of Pharm Exec’s 2011 Emerging Pharma leaders, recently spoke with Associate Editor Jennifer Ringler on building leadership and team rapport in today’s lean organization.
Posted in Agency Insight, Corporate Responsibility, leadership | Tagged , , , , , | 2 Comments